Location: Home
  • search
  • go
  • Relate News
  • 12/17/2010Shanxi Zhendong Pharma to launch IPO in Shenzhen's Chinext
  • 12/17/2010Northeast to build CNY 5B facility for fosfomycin
  • 12/17/2010BioDiem get Chinese and U.S. patents for anti-infective compound
  • 12/17/2010DSM sells 50% stake of penicillin unit to Sinochem Group
  • 12/16/2010Beijing to implement electronic patient records and DRGs in 2011
  • 12/16/2010Local governments crackdown on commercial briberies in hospitals
  • 12/16/2010Upcoming Event: Clinical Project Management Training Course
  • 12/16/2010China's antibiotic consumption ten times of global average
  • 12/16/2010SciClone Pharma drops failed hepatitis C program
  • 12/16/2010China makes new IP commitments at the latest U.S.-China JCCT
  • 12/15/2010IMS: Review of the Chinese Hospital Drug Market MAT 3Q/2010
  • 12/15/2010Chinese pandemic vaccine found safe and effective
  • 12/15/2010China accounts for 13% of pharma sales reps worldwide
  • 12/15/2010China and India to join hands to supply the global drug market
  • 12/14/2010CMA publishes hepatitis B prevention and therapeutic guide
  • 12/14/2010Handa Pharma announces tentative approval of its first-to-file ANDA fo...
  • 12/14/2010China Biologic Products appoints new president
  • 12/14/2010Lundbeck to copromote Lexapro with XiAn Janssen following sales force ...
  • 12/14/2010WSJ: Drug Research Gets New Asian Focus
  • 12/14/2010Shanghai Pharma acquires antibiotic business from parent company
  • 12/14/2010Zhejiang Jolly Pharma to IPO at Chinext
  • 12/13/2010Xinhua interview vice health minister over public hospital reform pilo...
  • 12/13/2010GE appoints new leader at GE Healthcare China
  • 12/13/2010WSJ: Selling Health Food to China
  • 12/13/2010Former Merck emerging market head to lead Merck KGaA
  • 12/13/2010Shanghai initiates NEDS with 388 additional drugs and zero margins
  • 12/13/2010Central government funded 50,000 new medical institutions in the past ...
  • 12/13/2010Shanghai Fosun acquires leading tuberculosis player Hongqi Pharma
  • 12/10/2010China's public health priority shifts to chronic disease
  • 12/10/2010Chi-Med increases stake in joint venture with Baiyunshan
  • Page:619/800 Total number of articles:23988: [First][<<] [617] [618] [619] [620] [621] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group